Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Parotid Sparing IMRT for Nasopharyngeal Cancer

NCT02149641 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT02149641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02149641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Parotid Sparing IMRT for Nasopharyngeal Cancer
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
April 30, 2012
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensity modulated radiotherapy with chemotherapy, nasopharyngeal cancers